Guidance for Industry Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies DRAFT GUIDANCE This guidance document is being distributed for comment…
Microsoft PowerPoint - WONG KC-IFPMA High Level Bio vs Small Mol vF.pptx International Federation f Ph ti lof Pharmaceutical Manufacturers & Associations Points To Consider…
Company Logo Key Success Factors of Biosimilar & Bio-better HyukJong Lee (E-mail: [email protected]) www.companyurl.co.kr HyukJong (HJ) Lee BA, Business Administration,…
BIOSIMILAR: A PURVIEW IP & Communication BIOLOGICS • Biopharmaceuticals such as therapeutic proteins, DNA vaccines, monoclonal antibodies, fusion proteins, gene therapy,…
CLINICAL TRIAL EDC TASK GROUP OF PHRMA BIOSTATISTICS & DATA MANAGEMENT TECHNICAL GROUP POSITION PAPER Electronic Clinical Data Capture Position Paper Revision 1 May 1,…
1. Rare Diseases and FDASIA Gayatri R. Rao MD, JD Director Office of Orphan Products Development (OOPD), FDA Rare Disease Congressional Caucus Briefing November 14, 2012…